Contact Investor Relations

Overview

Email Alerts
Charlotte's Web

For investor related questions please contact us via the information below.

Charlotte’s Web Holdings, Inc.
Investor Relations
700 Tech Court, Louisville CO 80027, United States

Email: IR[at]Charlottesweb.com

Canada: (416) 594-3849

USA: (720) 484-8930

For general questions about the Company and Charlotte’s Web Products:

Please visit our Frequently Asked Questions, or feel free to contact us via email or phone.
Contact Us via Email
Phone: +1(855) 790-8169

Investor Contact

Cory Pala

Investor Relations

Canada: (416) 594-3849
USA: (720) 484-8930

IR[at]charlottesweb.com

Charlotte's Web Holdings, INC.

For general questions & inquiries:

+1(855) 790-8169

700 Tech Court
Louisville CO 80027
United States

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Charlotte's Web, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Charlotte's Web to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *
Press Release Quarterly and Annual Reports Events Presentations End of Day Stock Quote

Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

Our Company

Overview
Stock Info

Financials
Governance

Press Releases
Events & Presentation

Investor Resources
Corporate Website

Our Company
Overview
Stock Info
Financials

Governance
Press Releases
Events & Presentation
Investor Resources
Corporate Website

* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

§ This product is tested by high performance liquid chromatography to ensure it contains no more than 13 parts per million tetrahydrocannabinol (THC).